|
个人基本信息
性别：保密 生日：1988-02-19
所在城市： QQ：
联系MSN：
注册日期：2017-05-25 08:07:02
自我介绍：By John Miller ZURICH, <A HREF="http://beautyamazing.com/beautynetwork/index.php?a=profile&u=iguve">beautyamazing.com</A> Nov 14 (Reuters) - Signals <a href="http://innkeeper.cba.pl/index.php?action=profile;u=1108">innkeeper.cba.pl</a> from Swiss drugmaker Novartis that it could unload its <a href="http://dmatloff-enterprises.com/advguestbook/">http://dmatloff-enterprises.com</a> struggling Alcon eyecare business is the latest step in dismantling former leader Dan Vasella's vision of building a European healthcare giant. <u><b>The transformation, however, is not proving to be easy.</b></u> Chairman Joerg Reinhardt said at the weekend that Alcon's woes have intensified soul-searching over the unit's future. "All options are open in the future," Chairman Joerg Reinhardt said in an interview in Swiss weekly SonntagsZeitung.<br /><br /><b>"In the long run, the question arises as to whether we are the best owner for Alcon."</b> <A HREF='http://www.gold-line.su/forum/user/77176/'>calominal</A> Vasella's $52 billion takeover of Alcon from Swiss foodmaker Nestle <A HREF='http://www.mixta-tunisia.com/index.php?option=com_phocaguestbook&id=1'>http://www.mixta-tunisia.com/index.php?option=com_phocaguestbook&id=1</A> was completed in 2010 as part of his empire-bulding. Since he departed in 2013, Novartis has reversed course, focusing on its prescription drugs business, including an emphasis <A HREF='http://ansenvironnement.com-ans.be/groupes/dzialanie-desnoranu/'>http://ansenvironnement.com-ans.be/groupes/dzialanie-desnoranu</A> on cancer medicines and its Sandoz generics unit. "Novartis under Vasella was going <a href="http://wiki.shaiya.com.ph/index.php?title=desnoran">co to za strona</a> be the Johnson & Johnson of Europe," said Stefan Schneider, a Bank Vontobel analyst in Zurich.<br /><br /> "Since Vasella has gone, they've started transforming the business." Alcon's uncertain future contrasts with the buoyant mood when Novartis upped its stake. At the time, Vasella lauded it for core operating profit margins of about 35 percent, better <a href="http://parmen.com.ua/ua/kunena/3-razdel-predlozhenij/4979-ulotka-desnoran">4985</a> than for drugs.
|
个人动态信息
最后登录时间：2017-05-25 08:07:02
最后登录IP所在地：瑞典
主页被访问数：651
主页最近被访问日期：2024-05-15 04:40
|
